Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes

Psychiatric Genetics

Volumn 24, Issue 6, 2014, Pages 269-272

  Radoeva, Petya ^a   Coman, Ioana ^a   Salazar, Cynthia ^a   Gentile, Karen ^a   Higgins, Anne ^b   Middleton, Frank ^a   Antshel, Kevin ^a   Fremont, Wanda ^a   Shprintzen, Robert ^b   Morrow, Bernice ^c   Kates, Wendy ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Virtual Center for Velo Cardio Facial Syndrome   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

22q11.2 deletion; autism spectrum disorder; catechol O methyltransferase; proline dehydrogenase; velocardiofacial syndrome

Indexed keywords

CATECHOL METHYLTRANSFERASE; PROLINE DEHYDROGENASE; PRODH PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTISM; CHILD; CHROMOSOME 22; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; VELOCARDIOFACIAL SYNDROME; DIGEORGE SYNDROME; GENETICS; YOUNG ADULT;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; FEMALE; GENOTYPE; HUMANS; MALE; PROLINE OXIDASE; YOUNG ADULT;

EID: 84930088963     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0000000000000062     Document Type: Article

References (34)

1. Antshel KM, Aneja A, Strunge L, Peebles J, Fremont WP, Stallone K, et al. (2007). Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J Autism Dev Disord 37:1776-1786.
2. Antshel KM, Fremont W, Kates WR (2008). The neurocognitive phenotype in velo-cardio-facial syndrome: a developmental perspective. Dev Disabil Res Rev 14:43-51.
3. Bassett AS, Chow EW (2008). Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 10:148-157.
4. Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EW (2007). Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry 61:1135-1140.
5. Bender HU, Almashanu S, Steel G, Hu CA, Lin WW, Willis A, et al. (2005). Functional consequences of PRODH missense mutations. Am J Hum Genet 76:409-420.
6. Bennetto L, Pennington BF, Rogers SJ (1996). Intact and impaired memory functions in autism. Child Dev 67:1816-1835.
7. Coman IL, Gnirke MH, Middleton FA, Antshel KM, Fremont W, Higgins AM, et al. (2010). The effects of gender and catechol O-methyltransferase (COMT) Val108/158Met polymorphism on emotion regulation in velo-cardio-facial syndrome (22q11.2 deletion syndrome): an fMRI study. Neuroimage 53:1043-1050.
8. Delwing D, Bavaresco CS, Wannmacher CM, Wajner M, Dutra-Filho CS, Wyse AT (2003). Proline induces oxidative stress in cerebral cortex of rats. Int J Dev Neurosci 21:105-110.
9. Fine SE, Weissman A, Gerdes M, Pinto-Martin J, Zackai EH, McDonald-McGinn DM, Emanuel BS (2005). Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35:461-470.
10. Geschwind DH (2011). Genetics of autism spectrum disorders. Trends Cogn Sci 15:409-416.
11. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, et al. (1999). The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434-439.
12. Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, et al. (2009). Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 48:1060-1068.
13. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et al. (2009). Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947-956.
14. Joseph RM, Steele SD, Meyer E, Tager-Flusberg H (2005). Self-ordered pointing in children with autism: failure to use verbal mediation in the service of working memory?. Neuropsychologia 43:1400-1411.
15. Jungerius BJ, Hoogendoorn ML, Bakker SC, Van't Slot R, Bardoel AF, Ophoff RA, et al. (2008). An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol Psychiatry 13:1060-1068.
16. Karayiorgou M, Gogos JA (2004). The molecular genetics of the 22q11-Associated schizophrenia. Brain Res Mol Brain Res 132:95-104.
17. Kates WR, Antshel KM, Fremont WP, Shprintzen RJ, Strunge LA, Burnette CP, Higgins AM (2007). Comparing phenotypes in patients with idiopathic autism to patients with velocardiofacial syndrome (22q11 DS) with and without autism. Am J Med Genet A 143A:2642-2650.
18. Kates WR, Antshel KM, Faraone SV, Fremont WP, Higgins AM, Shprintzen RJ, et al. (2011). Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry 69:945-952.
19. Kaufmann WE, Cortell R, Kau AS, Bukelis I, Tierney E, Gray RM, et al. (2004). Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet A 129A:225-234.
20. Limprasert P, Maisrikaw W, Sripo T, Ruangdaraganon N, Hansakunachai T, Roongpraiwan R, et al. (2008). Association of COMT Val158Met with autism spectrum disorders in Thai children. The American Society of Human Genetics, 58th Annual Meeting. Philadelphia PA, November 2008.
21. Lord C, Rutter M, Le Couteur A (1994). Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659-685.
22. Magnae MJ, Lamme VA, de Sain-van der Velden MG, Vorstman JA, Kemner C (2011). Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome. PLoS One 6:e25882.
23. Murphy KC (2002). Schizophrenia and velo-cardio-facial syndrome. Lancet 359:426-430.
24. Pasca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Pasca AM, et al. (2011). Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 17:1657-1662.
25. Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, Mukai J, et al. (2005). Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 8:1586-1594.
26. Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007). Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61:482-486.
27. Prasad SE, Howley S, Murphy KC (2008). Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome. Dev Disabil Res Rev 14:26-34.
28. Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, et al. (2007). Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 16:83-91.
29. Shprintzen RJ (2005). Velo-cardio-facial syndrome. Prog Pediatr Cardiol 20:187-193.
30. Sobin C, Kiley-Brabeck K, Karayiorgou M (2005). Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry 10:553-562.
31. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119:19-31.
32. Tunbridge EM, Harrison PJ, Weinberger DR (2006). Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60:141-151.
33. Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, et al. (2006). The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45:1104-1113.
34. Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, et al. (2009). Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 34:739-746.